Nakanishi Keita, Daiko Hiroyuki, Kato Fumihiko, Kanamori Jun, Igaki Hiroyasu, Tachimori Yuji, Koyanagi Kazuo
Department of Esophageal Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Department of Digestive Surgery, Keiyukai Sapporo Hospital, 1, 14 cho-me kita, Hondori, Shiroishi-ku, Sapporo, 003-0027, Japan.
Gen Thorac Cardiovasc Surg. 2019 May;67(5):470-478. doi: 10.1007/s11748-019-01070-1. Epub 2019 Feb 18.
There is no consensus concerning whether the residual stomach should be preserved after esophagectomy for thoracic esophageal cancer patients with previous distal or segmental gastrectomy. The purpose of this retrospective study was to assess the efficacy of preserving the residual stomach after esophagectomy in patients with previous gastrectomy.
Between 2000 and 2015, 45 consecutive thoracic esophageal cancer patients with previous distal or segmental gastrectomy underwent esophagectomy followed by colon reconstruction. Patients were assigned to two groups according to how the residual stomach was treated (preservation group, n = 11; resection group, n = 34). We compared surgical outcomes and alterations of nutrition status, including the skeletal muscle area, between the two groups. In addition, we investigated the distribution of abdominal lymph node metastases in the resection group.
Operative time and blood loss tended to be lower in the preservation group compared to the resection group. However, the difference did not reach statistical significance. The rate of patients decreasing skeletal muscle area after surgery was significantly higher in the resection group (88% vs 50%, P = 0.03). There were no patients with metastatic abdominal lymph nodes when the previous gastrectomy had been performed for gastric cancer and the esophageal cancer was located at the upper or middle esophagus in the resection group.
Preservation of the residual stomach after esophagectomy in esophageal cancer patients with previous gastrectomy may influence the postoperative nutrition status and can be selectively approved.
对于先前接受过远端或部分胃切除术的胸段食管癌患者,在食管切除术后是否应保留残胃尚无共识。本回顾性研究的目的是评估在先前接受过胃切除术的患者中,食管切除术后保留残胃的疗效。
2000年至2015年期间,45例连续的先前接受过远端或部分胃切除术的胸段食管癌患者接受了食管切除术,随后进行结肠重建。根据残胃的处理方式将患者分为两组(保留组,n = 11;切除组,n = 34)。我们比较了两组的手术结果以及营养状况的变化,包括骨骼肌面积。此外,我们调查了切除组腹部淋巴结转移的分布情况。
与切除组相比,保留组的手术时间和失血量有降低的趋势。然而,差异未达到统计学意义。切除组术后骨骼肌面积减少的患者比例明显更高(88%对50%,P = 0.03)。在切除组中,当先前因胃癌进行胃切除术且食管癌位于食管上段或中段时,没有患者出现腹部淋巴结转移。
对于先前接受过胃切除术的食管癌患者,食管切除术后保留残胃可能会影响术后营养状况,可选择性地予以批准。